Published in Cancer Weekly, April 26th, 2005
"We have examined the association of the CCND1 A/G(870) polymorphism with susceptibility and outcome in 174 German patients with oral SCC (OSCC).
"The CCND1 G 870 allele frequency was increased in cases (G(870)=0.65) when compared to controls (n=155, G(870)=0.54) and the distribution of CCND1 genotypes were significantly different (p=0.014)," scientists writing in the journal Oral Oncology report.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.